Hvilken er prisen på Gentian Diagnostics AS (GENT)

Prisen på Gentian Diagnostics AS (GENT) er $4.07

Hva er markedsverdien på Gentian Diagnostics AS (GENT)

Markedsverdien på Gentian Diagnostics AS (GENT) er $62.87M

Gentian Diagnostics AS (GENT) Prishistorikk

Gentian Diagnostics ASA develops, manufactures, and sells biochemical reagents for use in medical diagnostics and research in the United States, Asia, and Europe. It offers in-vitro diagnostic reagents for clinical chemistry analyzers, such as Gentian Calprotectin Immunoassay, a turbidimetric assay used for the measurement of circulating calprotectin in plasma and serum for detection and assessment of inflammation; Gentian Cystatin C Immunoassay test kit, a GFR marker for the diagnosis and therapeutic control of renal function and chronic kidney disease; Gentian Retinol-Binding Protein Immunoassay for detection of retinol-binding protein in human serum and plasma; and Canine CRP Immunoassay test kit, a particle-enhanced turbidimetric immunoassay for quantitative determination of canine C-reactive protein in dog plasma and serum. The company also develops faecal calprotectin immunoassay turbo that offers results of calprotectin concentration in stool supporting diagnosis of inflammatory bowel disease; and faecal pancreatic elastase immunoassay turbo, which allows analysis of pancreatic elastase in stool to aid in diagnosis of pancreatic exocrine insufficiency. Gentian Diagnostics ASA was founded in 2001 and is headquartered in Moss, Norway.

År	Ytelse
2026 (TTM)	-13.19%
2025	57.49%
2024	-6.42%
2023	-9.40%
2022	-48.17%
2021	21.42%
2020	12.57%
2019	-11.70%
2018	32.41%
2017	16.61%
2016	0.00%

År

Ytelse

2026 (TTM)

-13.19%

2025

57.49%

2024

-6.42%

2023

-9.40%

2022

-48.17%

2021

21.42%

2020

12.57%

2019

-11.70%

2018

32.41%

2017

16.61%

2016

0.00%

Selskap	Aksjepris	Endring 1år%	Land
STERIS plc STE.US	$237.91	-5.54%	IE
Shanghai United Imaging Healthcare Co., Ltd. 688271.SS	$15.36	-18.67%	CN
Ypsomed Holding AG YPSN.SW	$526.73	3.88%	CH
Medacta Group S.A. MOVE.SW	$167.77	-8.50%	CH
Jafron Biomedical Co.,Ltd. 300529.SZ	$2.28	-30.99%	CN

Selskap

Aksjepris

Endring 1år%

Land